US8006771062 - Common Stock

0.45  -0.03 (-7.22%)

After market: 0.47 +0.02 (+4.44%)

News Image
13 days ago - Chartmill

What's going on in today's after hours session

Curious about the stocks that are showing activity after the closing bell on Tuesday?

News Image
19 days ago - Bloomberg

A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs

Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this month. It’s also a blow to Jerry Walter, who’s lost five family members and suffered kidney, lung, hearing and heart damage from a rare disease.

News Image
a month ago - Seeking Alpha

RBC Capital downgrades Sangamo as biotech moves to save cash (SGMO)

RBC Capital downgrades Sangamo Therapeutics (SGMO) due to workforce cuts and program pauses, lowering price target to $2 from $6. Read more here.

News Image
2 months ago - Seeking Alpha

Sangamo Therapeutics 10% owner Biogen discloses sale of 6M shares (NASDAQ:SGMO)

Sangamo Therapeutics (SGMO) sells 6 million shares for $3 million, according to recent disclosure.

News Image
3 months ago - Market News Video

Notable Wednesday Option Activity: OXY, SGMO, ZM

News Image
4 months ago - InvestorPlace

Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases

Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday!

News Image
8 months ago - Seeking Alpha

Sangamo downgraded to underperform at BofA on restructuring (NASDAQ:SGMO)

BofA Securities has downgraded Sangamo Therapeutics (SGMO) to underperform as the company is undergoing a restructuring to address cash concerns. Read more here.